In brief, the CDH13 genotypes exhibited significant associations with the adiponectin levels (criterion 1), which in turn, conferred considerably positive effects on the fasting plasma glucose levels, QUICKI, HDL cholesterol and triglyceride levels and metabolic syndrome (criterion 2). The gene discussed is ADIPOQ; the disease is metabolic syndrome.